1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients

Abstract Background The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open forum infectious diseases 2023-11, Vol.10 (Supplement_2)
Hauptverfasser: Kim, Tae-Hwan, Shin, Ji Seong, Kim, Sin Young, Jang, Min Sik, Kim, Jihye
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_2
container_start_page
container_title Open forum infectious diseases
container_volume 10
creator Kim, Tae-Hwan
Shin, Ji Seong
Kim, Sin Young
Jang, Min Sik
Kim, Jihye
description Abstract Background The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics use may be an important etiologic factor. We aimed to assess the association between antibiotics use and the development of KD. Methods A population-based, case-control study was performed using data from 2010 to 2019 from the Health Insurance Review and Assessment Service (HIRA) database. Various profiles regarding prior antibiotics use since birth were compared between patients with KD and matched controls. Children aged < 5 years who were diagnosed with initial episode of KD from 2016 to 2019 were identified. Propensity score-matched controls without KD were selected from the general population in a 1:5 ratio. Four separate study cohorts according to four different periods of antibiotics use were created: 1) within 28 days after birth; 2) within 12 months after birth; 3) within 6 months from the index date; and 4) within 12 months from the index date. The occurrence of KD were compared between KD cases and controls. Results Overall, 17,818 patients with KD and 89,090 matched controls were included in the analysis. Use of antibiotics within 6 months (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.12–1.26) and 12 months (OR, 1.23; 95% CI, 1.14–1.32) from the index date were associated with the development of KD. The association between antibiotics use and KD (OR, 1.26; 95% CI, 1.17–1.37) was most prominent in patients who had received more than three classes of antibiotics within 12 months from the index date. No significant association was observed between the duration of antibiotics use, use of all three major antibiotics classes, or use of any specific antibiotics class and KD. Conclusion The development of KD is associated with antibiotics use. However, evidence suggesting that antibiotics use in the neonatal period or within the first 12 months of life is associated with KD is weak. Disclosures All Authors: No reported disclosures
doi_str_mv 10.1093/ofid/ofad500.1522
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ofid_ofad500_1522</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ofid/ofad500.1522</oup_id><sourcerecordid>10.1093/ofid/ofad500.1522</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1222-b9f4ee9212eac1746db966a0c62ce3edd8713b5a38c9aa291c37b222fd3b1fe3</originalsourceid><addsrcrecordid>eNqNkNtqAjEQhkNpoWJ9gN7lAVybg3tI78QeqVBBe73MJrOYVjdLEhHfow_cXZTSy97MDMN_gI-QW84mnCl552prugEmZd0nFeKCDIQURVKoNL_8c1-TUQifjDHOWcpyNSDfPCvUhM7drgVvg2uoq-msibayLlod6EdAWmE8IDZ0CdFiEwM92Lihb3CAAF-WPtiA0MmgMXTpXYtNsPFIV9p5THYQ9QZN19BE77bhnkJ3b5yPdBX35tj3cZaNFSt-82_IVQ3bgKPzHpL10-N6_pIs3p9f57NForkQIqlUPUVUggsEzfNpZiqVZcB0JjRKNKbIuaxSkIVWAEJxLfOqM9ZGVrxGOST8FKu9C8FjXbbe7sAfS87KHmzZgy3PYMsebOcZnzxu3_5D_gOcC31T</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients</title><source>Open Access: Oxford University Press Open Journals</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Kim, Tae-Hwan ; Shin, Ji Seong ; Kim, Sin Young ; Jang, Min Sik ; Kim, Jihye</creator><creatorcontrib>Kim, Tae-Hwan ; Shin, Ji Seong ; Kim, Sin Young ; Jang, Min Sik ; Kim, Jihye</creatorcontrib><description>Abstract Background The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics use may be an important etiologic factor. We aimed to assess the association between antibiotics use and the development of KD. Methods A population-based, case-control study was performed using data from 2010 to 2019 from the Health Insurance Review and Assessment Service (HIRA) database. Various profiles regarding prior antibiotics use since birth were compared between patients with KD and matched controls. Children aged &lt; 5 years who were diagnosed with initial episode of KD from 2016 to 2019 were identified. Propensity score-matched controls without KD were selected from the general population in a 1:5 ratio. Four separate study cohorts according to four different periods of antibiotics use were created: 1) within 28 days after birth; 2) within 12 months after birth; 3) within 6 months from the index date; and 4) within 12 months from the index date. The occurrence of KD were compared between KD cases and controls. Results Overall, 17,818 patients with KD and 89,090 matched controls were included in the analysis. Use of antibiotics within 6 months (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.12–1.26) and 12 months (OR, 1.23; 95% CI, 1.14–1.32) from the index date were associated with the development of KD. The association between antibiotics use and KD (OR, 1.26; 95% CI, 1.17–1.37) was most prominent in patients who had received more than three classes of antibiotics within 12 months from the index date. No significant association was observed between the duration of antibiotics use, use of all three major antibiotics classes, or use of any specific antibiotics class and KD. Conclusion The development of KD is associated with antibiotics use. However, evidence suggesting that antibiotics use in the neonatal period or within the first 12 months of life is associated with KD is weak. Disclosures All Authors: No reported disclosures</description><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofad500.1522</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Kim, Tae-Hwan</creatorcontrib><creatorcontrib>Shin, Ji Seong</creatorcontrib><creatorcontrib>Kim, Sin Young</creatorcontrib><creatorcontrib>Jang, Min Sik</creatorcontrib><creatorcontrib>Kim, Jihye</creatorcontrib><title>1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients</title><title>Open forum infectious diseases</title><description>Abstract Background The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics use may be an important etiologic factor. We aimed to assess the association between antibiotics use and the development of KD. Methods A population-based, case-control study was performed using data from 2010 to 2019 from the Health Insurance Review and Assessment Service (HIRA) database. Various profiles regarding prior antibiotics use since birth were compared between patients with KD and matched controls. Children aged &lt; 5 years who were diagnosed with initial episode of KD from 2016 to 2019 were identified. Propensity score-matched controls without KD were selected from the general population in a 1:5 ratio. Four separate study cohorts according to four different periods of antibiotics use were created: 1) within 28 days after birth; 2) within 12 months after birth; 3) within 6 months from the index date; and 4) within 12 months from the index date. The occurrence of KD were compared between KD cases and controls. Results Overall, 17,818 patients with KD and 89,090 matched controls were included in the analysis. Use of antibiotics within 6 months (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.12–1.26) and 12 months (OR, 1.23; 95% CI, 1.14–1.32) from the index date were associated with the development of KD. The association between antibiotics use and KD (OR, 1.26; 95% CI, 1.17–1.37) was most prominent in patients who had received more than three classes of antibiotics within 12 months from the index date. No significant association was observed between the duration of antibiotics use, use of all three major antibiotics classes, or use of any specific antibiotics class and KD. Conclusion The development of KD is associated with antibiotics use. However, evidence suggesting that antibiotics use in the neonatal period or within the first 12 months of life is associated with KD is weak. Disclosures All Authors: No reported disclosures</description><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNqNkNtqAjEQhkNpoWJ9gN7lAVybg3tI78QeqVBBe73MJrOYVjdLEhHfow_cXZTSy97MDMN_gI-QW84mnCl552prugEmZd0nFeKCDIQURVKoNL_8c1-TUQifjDHOWcpyNSDfPCvUhM7drgVvg2uoq-msibayLlod6EdAWmE8IDZ0CdFiEwM92Lihb3CAAF-WPtiA0MmgMXTpXYtNsPFIV9p5THYQ9QZN19BE77bhnkJ3b5yPdBX35tj3cZaNFSt-82_IVQ3bgKPzHpL10-N6_pIs3p9f57NForkQIqlUPUVUggsEzfNpZiqVZcB0JjRKNKbIuaxSkIVWAEJxLfOqM9ZGVrxGOST8FKu9C8FjXbbe7sAfS87KHmzZgy3PYMsebOcZnzxu3_5D_gOcC31T</recordid><startdate>20231127</startdate><enddate>20231127</enddate><creator>Kim, Tae-Hwan</creator><creator>Shin, Ji Seong</creator><creator>Kim, Sin Young</creator><creator>Jang, Min Sik</creator><creator>Kim, Jihye</creator><general>Oxford University Press</general><scope>TOX</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20231127</creationdate><title>1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients</title><author>Kim, Tae-Hwan ; Shin, Ji Seong ; Kim, Sin Young ; Jang, Min Sik ; Kim, Jihye</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1222-b9f4ee9212eac1746db966a0c62ce3edd8713b5a38c9aa291c37b222fd3b1fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Tae-Hwan</creatorcontrib><creatorcontrib>Shin, Ji Seong</creatorcontrib><creatorcontrib>Kim, Sin Young</creatorcontrib><creatorcontrib>Jang, Min Sik</creatorcontrib><creatorcontrib>Kim, Jihye</creatorcontrib><collection>Open Access: Oxford University Press Open Journals</collection><collection>CrossRef</collection><jtitle>Open forum infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Tae-Hwan</au><au>Shin, Ji Seong</au><au>Kim, Sin Young</au><au>Jang, Min Sik</au><au>Kim, Jihye</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients</atitle><jtitle>Open forum infectious diseases</jtitle><date>2023-11-27</date><risdate>2023</risdate><volume>10</volume><issue>Supplement_2</issue><issn>2328-8957</issn><eissn>2328-8957</eissn><abstract>Abstract Background The etiology of the Kawasaki disease (KD) has been explained by the influence of infectious agents that interfere with the immune function in genetically susceptible children. In addition of this infectious etiology, we hypothesized that microbial imbalance in the gut from antibiotics use may be an important etiologic factor. We aimed to assess the association between antibiotics use and the development of KD. Methods A population-based, case-control study was performed using data from 2010 to 2019 from the Health Insurance Review and Assessment Service (HIRA) database. Various profiles regarding prior antibiotics use since birth were compared between patients with KD and matched controls. Children aged &lt; 5 years who were diagnosed with initial episode of KD from 2016 to 2019 were identified. Propensity score-matched controls without KD were selected from the general population in a 1:5 ratio. Four separate study cohorts according to four different periods of antibiotics use were created: 1) within 28 days after birth; 2) within 12 months after birth; 3) within 6 months from the index date; and 4) within 12 months from the index date. The occurrence of KD were compared between KD cases and controls. Results Overall, 17,818 patients with KD and 89,090 matched controls were included in the analysis. Use of antibiotics within 6 months (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.12–1.26) and 12 months (OR, 1.23; 95% CI, 1.14–1.32) from the index date were associated with the development of KD. The association between antibiotics use and KD (OR, 1.26; 95% CI, 1.17–1.37) was most prominent in patients who had received more than three classes of antibiotics within 12 months from the index date. No significant association was observed between the duration of antibiotics use, use of all three major antibiotics classes, or use of any specific antibiotics class and KD. Conclusion The development of KD is associated with antibiotics use. However, evidence suggesting that antibiotics use in the neonatal period or within the first 12 months of life is associated with KD is weak. Disclosures All Authors: No reported disclosures</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/ofid/ofad500.1522</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)
issn 2328-8957
2328-8957
language eng
recordid cdi_crossref_primary_10_1093_ofid_ofad500_1522
source Open Access: Oxford University Press Open Journals; DOAJ Directory of Open Access Journals; PubMed Central; EZB Electronic Journals Library
title 1689. Comparison of Antibiotics Use between Patients with Kawasaki Disease and Propensity Score-matched Controls: a Cohort Study of 106,908 Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T06%3A37%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1689.%20Comparison%20of%20Antibiotics%20Use%20between%20Patients%20with%20Kawasaki%20Disease%20and%20Propensity%20Score-matched%20Controls:%20a%20Cohort%20Study%20of%20106,908%20Patients&rft.jtitle=Open%20forum%20infectious%20diseases&rft.au=Kim,%20Tae-Hwan&rft.date=2023-11-27&rft.volume=10&rft.issue=Supplement_2&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofad500.1522&rft_dat=%3Coup_cross%3E10.1093/ofid/ofad500.1522%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/ofid/ofad500.1522&rfr_iscdi=true